✓
Open
16 Jul 2021
✓
Close
20 Jul 2021
3
Allotment
—
✓
Listing
Thu, Jul 29, 2021
Price Band
₹1073 to ₹1083
Issue Size
46,16,804 shares (agg. up to ₹500 Cr)
Lot Size
13 Shares
Listing Date
Thu, Jul 29, 2021
Latest GMP
₹1110
Est. Gain
102.49%
✦ AI Insight
GMP Trend
29-07-2021₹1110Est. ₹2193+102.49%
28-07-2021₹1130Est. ₹2213+104.34%
27-07-2021₹1125Est. ₹2208+103.88%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 124.52x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2021 | 31 Mar 2020 | 31 Mar 2019 |
|---|---|---|---|
| Assets | 314.80 | 248.94 | 187.51 |
| Total Income | 306.29 | 264.62 | 206.80 |
| Profit After Tax | 52.26 | 37.79 | 20.54 |
| EBITDA | 71.64 | 56.34 | 34.30 |
| NET Worth | 165.96 | 117.69 | 79.70 |
| Reserves and Surplus | 145.88 | 109.66 | 71.67 |
| Total Borrowing | 90.25 | 90.69 | 77.15 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Clean Science & Technology Ltd. | Mainboard | ₹1,546.62 Cr | ₹900 | null | ₹1,585.25 | +76.14% | ₹768.35 (-0.44%) |
| Laxmi Organic Industries Ltd. | Mainboard | ₹600.00 Cr | ₹130 | null | ₹164.45 | +26.50% | ₹170.96 (+1.18%) |
| Anupam Rasayan India Ltd. | Mainboard | ₹760.00 Cr | ₹555 | null | ₹526.80 | -5.08% | ₹1,269.00 (+0.25%) |
| Chemcon Speciality Chemicals Ltd. | Mainboard | ₹318.00 Cr | ₹340 | null | ₹584.80 | +72.00% | ₹184.25 (+0.65%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding capital expenditure requirements for expansion of our Dahej Manufacturing Facility | 147.10 |
| 2 | Funding capital expenditure requirements for upgradation at our R&D facility in Vadodara; and | 23.97 |
| 3 | General corporate purposes | 36.21 |
About Tatva Chintan Pharma Chem IPO
Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India. The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations. Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat. Competitive strengths Leading manufacturer of structure directing agents and phase transfer catalyst. Diversified product portfolio. Global ma
Contact Details
Tatva Chintan Pharma Chem Ltd. AddressPlot No.502 / 17, GIDC Estate, AnkleshwarBharuchBharuch, Gujarat, 393002+91 75730 46951cs@tatvachintan.comVisit Website